KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Equity Ratio (2017 - 2025)

Moderna (MRNA) has disclosed Equity Ratio for 7 consecutive years, with 0.77 as the latest value for Q3 2025.

  • On a quarterly basis, Equity Ratio changed N/A to 0.77 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.77, a N/A change, with the full-year FY2024 number at 0.77, changed N/A from a year prior.
  • Equity Ratio was 0.77 for Q3 2025 at Moderna, up from 0.0 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.77 in Q4 2024 to a low of 0.0 in Q1 2025.
  • A 4-year average of 0.52 and a median of 0.57 in 2021 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: plummeted 61.91% in 2021, then soared 104.55% in 2022.
  • Moderna's Equity Ratio stood at 0.57 in 2021, then increased by 28.98% to 0.74 in 2022, then increased by 4.23% to 0.77 in 2024, then fell by 0.26% to 0.77 in 2025.
  • Per Business Quant, the three most recent readings for MRNA's Equity Ratio are 0.77 (Q3 2025), 0.0 (Q1 2025), and 0.77 (Q4 2024).